Hearing impairment during deferoxamine therapy for thalassemia major.
Argiolu
F
F
Diana
G
G
Avignone
A
A
Cao
A
A
Di Ninni
S
S
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000009:adverse effects*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D013789:Thalassemia / Q000150:complications* / Q000188:drug therapy
D003676:Deferoxamine